Sun Pharma net at Rs 350 crore

摘要

SUN Pharmaceutical Industries posted a net profit of Rs 350.15 crore for the third quarter ended December 2010, a marginal increase of 3.3 per cent over the Rs 338.95-crore net profit in the year-ago period. Israel-based Taro became a subsidiary of the company on September 20, and the results for the current period include the relevant results of Taro and its subsidiaries. Therefore, the corresponding figures for the previous periods are not comparable, said Sun Pharma.